{"id":632,"date":"2025-01-16T11:45:46","date_gmt":"2025-01-16T10:45:46","guid":{"rendered":"https:\/\/nuklid.network\/news\/radiopharmacy-radiance-made-in-saxony"},"modified":"2026-04-04T10:35:38","modified_gmt":"2026-04-04T08:35:38","slug":"radiopharmacy-radiance-made-in-saxony","status":"publish","type":"post","link":"https:\/\/nuklid.network\/en\/news\/radiopharmacy-radiance-made-in-saxony","title":{"rendered":"Radiopharmacy: Radiance made in Saxony"},"content":{"rendered":"

Saxon radiopharmacy network nukliD\u00ae strengthens international visibility<\/h2>\n<\/div><\/div><\/div><\/div><\/div><\/div>

Today, Thursday, January 16, 2025, leading German and international players in the field of radiopharmacy from Saxony agreed to intensify their collaboration. The aim of the partners from the fields of research, industry and cluster management is to develop radiopharmacy in Saxony into a center for innovation and expertise in this pioneering field and thus make it more visible internationally. To this end, they are joining forces under the name Radiopharmacy Cluster Dresden - nukliD\u00ae. <\/em><\/p><\/div><\/div><\/div><\/div>

Radiopharmaceuticals are special drugs containing radioactive elements, so-called isotopes. They make it possible to diagnose and treat tumours in a precise, targeted and personalized manner. Unlike conventional therapies, radiopharmaceuticals act directly in the diseased tissue, which means that the surrounding healthy tissue is largely spared. Radiopharmacy is developing into a key technology in modern nuclear medicine cancer treatment. With the founding of the Radiopharmacy Cluster Dresden - nukliD\u00ae<\/sup>, Saxon players in this innovative sector have now joined forces to bundle and further expand their potential. nukliD\u00ae<\/sup> will promote cooperation between science and industry, drive forward technical innovations and carry out public relations work. Another key objective is to train and secure highly qualified specialists and increase the international visibility of Saxony as a business location. <\/p><\/div><\/div>

\"Image\"<\/span>
Speech by Dr. Bj\u00f6rn Wolf, HZDR - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Speech by Andr\u00e9 Hofamann, CEO of biosaxony Management GmbH (soon to be leap_up GmbH) - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Minister President Michael Kretschmer with the founders of the new Radiopharmacy Cluster Dresden- nukliD - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Memorandum of Understanding for the Dresden Radiopharmacy Cluster \u2013 nukliD_Credit - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Marco M\u00fcller (CEO,ABX) - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Marco M\u00fcller (CEO, ABX) and Prime Minister Michael Kretschmer at the new cyclotron in Radeberg - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Marco M\u00fcller (CEO, ABX) and Prime Minister Michael Kretschmer at the new cyclotron in Radeberg - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Marco M\u00fcller (CEO, ABX) and Prime Minister Michael Kretschmer at the new cyclotron in Radeberg - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Marco M\u00fcller (CEO, ABX) and Prime Minister Michael Kretschmer at the new cyclotron in Radeberg - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
A message from Radeberg\u2019s Mayor Frank H\u00f6hme - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
A message from Radeberg\u2019s Mayor Frank H\u00f6hme - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
A message from Jan Pratzka, Dresden\u2019s Mayor for Economic Affairs - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
A message from Saxony\u2019s Minister President Michael Kretschmer - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Remarks by Saxony\u2019s Minister President Michael Kretschmer at the ceremonial signing of the MoU - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
A view of the audience, which included numerous representatives from the business, political, and research communities - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Welcome address by Marco M\u00fcller, CEO of ABX advanced biochemical compounds - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Andr\u00e9 Hofmann of biosaxony puts the final signature on the Memorandum of Understanding regarding nukliD - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div>
\"Image\"<\/span>
Speech by Dr. Bj\u00f6rn Wolf, HZDR - \u00a9 J\u00fcrgen L\u00f6sel \n<\/span>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/i><\/a><\/i><\/a><\/div><\/div>